The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
California tops 2 million coronavirus cases as officials fear holiday surge
California reached an alarming milestone Wednesday, surpassing more than 2 million confirmed cases of Covid-19 — the most of...
-
Pfizer says Covid vaccine more than 90 percent effective in kids
A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing...
-
Why scientists are talking about viral load and the delta variant
The delta variant of the coronavirus, now the most common strain circulating in the United States, is causing cases...
-
Once a darling of the pandemic, Germany now has more than 1 million vaccines unused in storage
At a time when vaccines are in such urgent demand, Germany has more than 1 million unused doses sitting...
-
Getting abortion pills by mail is already more complicated than it might seem
Google searches for the term “abortion pills” rose to an all-time high on May 3, the day Politico published...
-
Small pharmacies are crucial to vaccine distribution. But it could cost them.
Thousands of small pharmacies across the country were tapped by the Biden administration last week to stand on the...
-
Alex Azar resigns as Health and Human Services Secretary, citing Capitol mob
Alex Azar, the Health and Human Services Secretary, resigned earlier this week, citing the violent Capitol riot inflamed by...
-
‘The virus must be slowed down’: Macron puts France back into lockdown
IE 11 is not supported. For an optimal experience visit our site on another browser. 01:45 Share this –...
Recent Comments